Bioxytran, Inc.

BIXT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents — $11.1K $3.5K $6.2K $20.7K $5.5K $16.5K $22.8K
Accounts Receivable $23.0K $9.6K — — $58.3K $27.4K — —
Inventory $5.3K $6.3K — — $14.1K $11.8K $25.4K $7.5K
Total Current Assets $110 $27.0K $3.5K $6.2K $93.1K $299.4K $48.4K $30.4K
Property, Plant & Equipment $682.2K $24.7K $52.3K $107.1K $165.3K $129.1K $167.6K $50.3K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $110 $51.7K $55.8K $113.3K $258.4K $428.4K $216.1K $80.7K
Liabilities
Accounts Payable $11.3K $37.2K $91.1K $201.6K $34.1K $28.2K $10.1K $69.6K
Total Current Liabilities $1.4K $342.3K $251.0K $334.7K $183.0K $74.4K $52.8K $109.6K
Long-Term Debt — — — — — — — —
Total Liabilities $1.4K $342.3K $251.0K $334.7K $183.0K $74.4K $52.8K $136.7K
Stockholders' Equity
Retained Earnings $-86.4K $-13.9M $-13.2M $-11.1M $-9.7M — — —
Total Stockholders' Equity $-1.3K $-290.6K $-195.2K $-221.5K $75.4K $354.1K $163.3K $-56.0K
← Newer Page 2 of 2 Older →